Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)
{{output}}
Introduction: The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is the first line of defense against a plethora of environmental or endogenous deviations in redox metabolism, proteostasis, inflammation, etc. Therefore, pharmacological... ...
